GT
Gasami Therapeutics, Inc.
SEC filingBiotechnology · Richmond, VA
Amount raised$20Ksold at filing
Total offering$250K$230K still open
Investors in the raise1count reported to the SEC
FiledJan 12, 2026first sale Dec 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sarah Hunter-ChangExecutive Officer
Executive officers, directors and promoters as listed on the Form D.